Literature DB >> 12859328

Quality of generalist vs. specialty care for people with HIV on antiretroviral treatment: a prospective cohort study.

J Page1, R Weber, B Somaini, C Nöstlinger, K Donath, R Jaccard.   

Abstract

OBJECTIVES: To describe health-care use by persons with HIV in an urban area of Switzerland (Zurich). Further, to compare the different health-care settings.
DESIGN: A 1-year prospective cohort study recruiting 60 patients at general practices and 60 patients at a specialized university outpatient clinic.
METHODS: Patients and their treating physicians were interviewed or answered questionnaires, respectively, at baseline, month 6 and 12.
RESULTS: During the study period, five patient groups were identified among the 106 enrolled patients, of whom (i) 42% saw a general practitioner exclusively, (ii) 31% were treated at the specialized outpatient clinic, (iii) 8% were in shared care, (iv) 10% changed health-care model, and (v) 9% were lost to follow-up. Baseline demographic, psychosocial and clinical data were similar among patient groups. At study end, the proportion of patients with HIV-1 RNA < 400 copies/mL was 72%, 74%, 88%, 55% among groups (i) to (iv), respectively (ns), and 22% at month 6 among those lost to follow-up. Indicators for quality of care were similarly good among all patient groups.
CONCLUSIONS: A well-working system offers high-quality healthcare to persons living with HIV, where existing teams of specialty and primary health-care professionals efficiently and effectively co-operate.

Entities:  

Mesh:

Year:  2003        PMID: 12859328     DOI: 10.1046/j.1468-1293.2003.00157.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  9 in total

1.  An economic analysis of payment for health care services: the United States and Switzerland compared.

Authors:  Peter Zweifel; Ming Tai-Seale
Journal:  Int J Health Care Finance Econ       Date:  2009-04-09

2.  Human Immunodeficiency Virus (HIV) Quality Indicators Are Similar Across HIV Care Delivery Models.

Authors:  Corinne M Rhodes; Yuchiao Chang; Susan Regan; Daniel E Singer; Virginia A Triant
Journal:  Open Forum Infect Dis       Date:  2017-01-31       Impact factor: 3.835

3.  A population-based study evaluating family physicians' HIV experience and care of people living with HIV in Ontario.

Authors:  Claire E Kendall; Douglas G Manuel; Jaime Younger; William Hogg; Richard H Glazier; Monica Taljaard
Journal:  Ann Fam Med       Date:  2015-09       Impact factor: 5.166

4.  The quality of care for adults with epilepsy: an initial glimpse using the QUIET measure.

Authors:  Mary Jo Pugh; Dan R Berlowitz; Jaya K Rao; Gabriel Shapiro; Ruzan Avetisyan; Amresh Hanchate; Kelli Jarrett; Jeffrey Tabares; Lewis E Kazis
Journal:  BMC Health Serv Res       Date:  2011-01-03       Impact factor: 2.655

5.  Screening and prevention in Swiss primary care: a systematic review.

Authors:  David Eisner; Marco Zoller; Thomas Rosemann; Carola A Huber; Nina Badertscher; Ryan Tandjung
Journal:  Int J Gen Med       Date:  2011-12-16

6.  A population-based study comparing patterns of care delivery on the quality of care for persons living with HIV in Ontario.

Authors:  Claire E Kendall; Monica Taljaard; Jaime Younger; William Hogg; Richard H Glazier; Douglas G Manuel
Journal:  BMJ Open       Date:  2015-05-13       Impact factor: 2.692

7.  Non-Communicable Disease Preventive Screening by HIV Care Model.

Authors:  Corinne M Rhodes; Yuchiao Chang; Susan Regan; Virginia A Triant
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

8.  The variability and predictors of quality of AIDS care services in Brazil.

Authors:  Maria Ines Battistella Nemes; Regina Melchior; Cáritas Relva Basso; Elen Rose Lodeiro Castanheira; Maria Teresa Seabra Soares de Britto e Alves; Shaun Conway
Journal:  BMC Health Serv Res       Date:  2009-03-20       Impact factor: 2.655

9.  Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol.

Authors:  Lara R Fairall; Max O Bachmann; Merrick F Zwarenstein; Carl J Lombard; Kerry Uebel; Cloete van Vuuren; Dewald Steyn; Andrew Boulle; Eric D Bateman
Journal:  Trials       Date:  2008-04-23       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.